Trust CO Of Vermont Novo Nordisk A S Transaction History

Trust CO Of Vermont

  • $1.96 Billion
  • Q1 2025

A detailed history of Trust CO Of Vermont transactions in Novo Nordisk A S stock. As of the latest transaction made, Trust CO Of Vermont holds 26,690 shares of NVO stock, worth $1.66 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
26,690
Previous 26,981 1.08%
Holding current value
$1.66 Million
Previous $2.32 Million 20.13%
% of portfolio
0.09%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 24, 2025
SELL
$69.3 - $90.95 $20,166 - $26,466
-291 Reduced 1.08%
26,690 $1.85 Million
Q4 2024

Jan 15, 2025
SELL
$85.0 - $120.04 $88,740 - $125,321
-1,044 Reduced 3.73%
26,981 $2.32 Million
Q3 2024

Oct 16, 2024
SELL
$119.07 - $145.42 $69,298 - $84,634
-582 Reduced 2.03%
28,025 $3.34 Million
Q2 2024

Jul 09, 2024
SELL
$122.71 - $146.91 $65,281 - $78,156
-532 Reduced 1.83%
28,607 $4.08 Million
Q1 2024

May 03, 2024
BUY
$102.11 - $135.92 $1.15 Million - $1.53 Million
11,248 Added 62.87%
29,139 $3.74 Million
Q4 2023

Mar 08, 2024
SELL
$87.78 - $105.45 $914,755 - $1.1 Million
-10,421 Reduced 36.81%
17,891 $1.85 Million
Q3 2023

Nov 27, 2023
BUY
$90.94 - $199.54 $1.27 Million - $2.78 Million
13,919 Added 96.71%
28,312 $2.57 Million
Q2 2023

Jul 17, 2023
BUY
$155.98 - $172.65 $1.15 Million - $1.27 Million
7,350 Added 104.36%
14,393 $2.33 Million
Q4 2022

Feb 09, 2023
BUY
$102.55 - $135.33 $3,281 - $4,330
32 Added 0.46%
7,043 $953,000
Q3 2022

Oct 24, 2022
SELL
$95.28 - $116.93 $20,389 - $25,023
-214 Reduced 2.96%
7,011 $699,000
Q2 2022

Jul 20, 2022
SELL
$103.24 - $121.81 $20,441 - $24,118
-198 Reduced 2.67%
7,225 $806,000
Q4 2021

Jan 21, 2022
SELL
$95.88 - $117.08 $12,176 - $14,869
-127 Reduced 1.68%
7,423 $832,000
Q3 2021

Oct 22, 2021
SELL
$84.42 - $106.62 $16,884 - $21,324
-200 Reduced 2.58%
7,550 $725,000
Q2 2021

Jul 15, 2021
SELL
$67.66 - $84.76 $59,540 - $74,588
-880 Reduced 10.2%
7,750 $649,000
Q1 2021

Apr 16, 2021
SELL
$67.06 - $75.82 $5,029 - $5,686
-75 Reduced 0.86%
8,630 $582,000
Q4 2020

Feb 03, 2021
SELL
$63.89 - $73.8 $9,775 - $11,291
-153 Reduced 1.73%
8,705 $608,000
Q3 2020

Nov 06, 2020
SELL
$63.69 - $70.22 $4,458 - $4,915
-70 Reduced 0.78%
8,858 $615,000
Q2 2020

Jul 17, 2020
SELL
$58.54 - $67.94 $43,905 - $50,955
-750 Reduced 7.75%
8,928 $585,000
Q1 2020

Apr 24, 2020
SELL
$49.46 - $64.78 $2,720 - $3,562
-55 Reduced 0.57%
9,678 $583,000
Q4 2019

Feb 06, 2020
SELL
$49.86 - $58.26 $32,409 - $37,869
-650 Reduced 6.26%
9,733 $563,000
Q3 2019

Oct 24, 2019
SELL
$47.54 - $53.43 $28,999 - $32,592
-610 Reduced 5.55%
10,383 $537,000
Q2 2019

Jul 26, 2019
SELL
$46.79 - $52.47 $44,450 - $49,846
-950 Reduced 7.95%
10,993 $561,000
Q1 2019

May 01, 2019
SELL
$46.36 - $52.63 $55,863 - $63,419
-1,205 Reduced 9.16%
11,943 $625,000
Q4 2018

Jan 30, 2019
SELL
$41.54 - $47.25 $47,771 - $54,337
-1,150 Reduced 8.04%
13,148 $606,000
Q3 2018

Oct 26, 2018
SELL
$46.76 - $51.24 $100,300 - $109,909
-2,145 Reduced 13.05%
14,298 $674,000
Q2 2018

Jul 11, 2018
SELL
$44.29 - $50.42 $31,711 - $36,100
-716 Reduced 4.17%
16,443 $758,000
Q1 2018

May 18, 2018
SELL
$48.49 - $58.14 $272,271 - $326,456
-5,615 Reduced 24.66%
17,159 $845,000
Q4 2017

Feb 02, 2018
SELL
$47.53 - $53.73 $79,612 - $89,997
-1,675 Reduced 6.85%
22,774 $1.22 Million
Q3 2017

Oct 24, 2017
BUY
$41.15 - $49.22 $1.01 Million - $1.2 Million
24,449
24,449 $1.18 Million

Others Institutions Holding NVO

# of Institutions
1,861
Shares Held
337M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $140B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email